BMSCs alleviate inflammation and inhibit apoptosis in radiation pneumonitis treatment by modulating the NF-κB/NLRP3 signaling pathway
Journal of Radiation Research · 26.05.2026 · 67 (3) · 453-466
DOI: 10.1093/jrr/rrag029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 24.04.2026. Verfasst von Yiwei Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical Medical College, Qiqihar Medical University, No. 333 Bukui North Street, Jianhua District, Qiqihar 161006, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Apoptosis, Signal Transduction. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Heilongjiang Provincial Natural Science Foundation, Qiqihar Medical University Postgraduate Innovation Fund, Construction Project of Dominant Characteristic Disciplines of Qiqihar Medical University.
Abstract (Originalsprache)
Radiation pneumonitis (RP) is a severe consequence of thoracic radiation, and its pathophysiology is tightly linked to NLRP3 inflammasome-mediated hyperinflammatory reactions. The nuclear factor κB (NF-κB) signaling system, which regulates NLRP3, could be a potential therapeutic target. This study explores how bone marrow-derived mesenchymal stem cells (BMSCs) can treat RP via modifying the NF-κB/NLRP3 signaling pathway. BMSCs treatment significantly reduced inflammatory infiltration in rat lung tissue and decreased inflammatory cytokine release. Mechanistically, by inhibiting the NF-κB/NLRP3 signaling axis, BMSCs consequently reduce the secretion of key pro-inflammatory mediators, including IL-1β, IL-18, and TNF-α. Additionally, BMSCs suppressed apoptosis by downregulating inflammasome formation, achieving therapeutic effects against RP. BMSCs block NF-κB/NLRP3 signaling, reducing inflammasome production. They treat RP by inhibiting inflammasomes and suppressing apoptosis. This strategy is a novel therapy option for RP management and clinical prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Clinical Medical College, Qiqihar Medical University, No. 333 Bukui North Street, Jianhua District, Qiqihar 161006, China.
- College of Medical Technology, Qiqihar Medical University, No. 333 Bukui North Street, Jianhua District, Qiqihar 161006, China.
- Department of Radiation Oncology, The Third Affiliated Hospital of Qiqihar Medical University, No. 3, Taishun Street, Tiefeng District, Qiqihar 161000, China.
Förderung
- Heilongjiang Provincial Natural Science Foundation
- Qiqihar Medical University Postgraduate Innovation Fund
- Construction Project of Dominant Characteristic Disciplines of Qiqihar Medical University
Zitieren
APA
Song, Y., Wen, Y., Zhai, H., Zhang, N., & Tong, X. (2026). BMSCs alleviate inflammation and inhibit apoptosis in radiation pneumonitis treatment by modulating the NF-κB/NLRP3 signaling pathway. Journal of Radiation Research, 67(3), 453-466. https://doi.org/10.1093/jrr/rrag029
Vancouver
Song Y, Wen Y, Zhai H, Zhang N, Tong X. BMSCs alleviate inflammation and inhibit apoptosis in radiation pneumonitis treatment by modulating the NF-κB/NLRP3 signaling pathway. Journal of Radiation Research. 2026;67(3):453-466. doi:10.1093/jrr/rrag029
BibTeX
@article{Song2026,
author = {Song, Yiwei and Wen, Yuxin and Zhai, Huaqing and Zhang, Na and Tong, Xu},
title = {BMSCs alleviate inflammation and inhibit apoptosis in radiation pneumonitis treatment by modulating the NF-κB/NLRP3 signaling pathway},
journal = {Journal of Radiation Research},
year = {2026},
volume = {67},
number = {3},
pages = {453--466},
doi = {10.1093/jrr/rrag029}
}
EUVIMED